Akos Czibere
Vermogen: - $ op 31-08-2026
Vermogen: - $ op 31-08-2026
Akos Czibere currently works at Aktis Oncology, Inc., as Chief Medical Officer from 2024.
Dr. Czibere also formerly worked at Merrimack Pharmaceuticals, Inc., as Vice President-Clinical Development and Pfizer Inc., as Vice President-Therapeutic Area.
Dr. Czibere received his doctorate degree from Heinrich-Heine-Universität Düsseldorf.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AKTIS ONCOLOGY, INC. -.--% | 23-09-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| AKTIS ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Heinrich-Heine-Universität Düsseldorf
Heinrich-Heine-Universität Düsseldorf Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aktis Oncology, Inc.
Aktis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers radiopharmaceuticals to treat tumor cancers | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau